WT
BNTX icon

Whittier Trust’s BioNTech BNTX Stock Holding History

Whittier Trust’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-52
Closed -$5.54K – 1425
2025
Q2 		$5.54K Sell
52
-2,000
-97% -$202K ﹤0.01% 1327
2025
Q1 		$187K Buy
2,052
+2,000
+3,846% +$224K ﹤0.01% 663
2024
Q4 		$5.92K Hold
52
– – ﹤0.01% 1345
2024
Q3 		$6.18K Hold
52
– – ﹤0.01% 1347
2024
Q2 		$4.18K Hold
52
– – ﹤0.01% 1359
2024
Q1 		$4.8K Hold
52
– – ﹤0.01% 1358
2023
Q4 		$5.49K Hold
52
– – ﹤0.01% 1317
2023
Q3 		$5.65K Hold
52
– – ﹤0.01% 1354
2023
Q2 		$5.61K Sell
52
-85
-62% -$9.56K ﹤0.01% 1355
2023
Q1 		$17.1K Buy
137
+38
+38% +$5.22K ﹤0.01% 1187
2022
Q4 		$14.9K Buy
99
+14
+16% +$2.15K ﹤0.01% 1209
2022
Q3 		$11K Hold
85
– – ﹤0.01% 1319
2022
Q2 		$13K Hold
85
– – ﹤0.01% 1263
2022
Q1 		$14K Buy
+85
New +$14.3K ﹤0.01% 1274

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Whittier Trust's BNTX Position: Q3 2025 in Review

Whittier Trust sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 52 shares — an estimated $5.54K sold.

Whittier Trust first reported a position in BNTX in Q1 2022 and held it in 14 quarters. The position peaked at $187K in Q1 2025. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Whittier Trust reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Whittier Trust sold 52 BioNTech shares in Q3 2025, an estimated $5.54K.
  • Whittier Trust first reported a position in BioNTech in Q1 2022 and held it in 14 quarters.
  • Whittier Trust's BioNTech position peaked at $187K in Q1 2025.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Whittier Trust's 13F filing for Q3 2025, filed 31 Oct 2025.